Compare Sun Pharma with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs CADILA HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA CADILA HEALTHCARE SUN PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x 70.0 30.2 232.0% View Chart
P/BV x 3.5 6.2 56.8% View Chart
Dividend Yield % 0.6 0.6 108.0%  

Financials

 SUN PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
CADILA HEALTHCARE
Mar-20
SUN PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs484352 137.4%   
Low Rs315207 152.6%   
Sales per share (Unadj.) Rs136.9139.2 98.3%  
Earnings per share (Unadj.) Rs17.411.5 152.0%  
Cash flow per share (Unadj.) Rs26.018.3 142.2%  
Dividends per share (Unadj.) Rs4.003.50 114.3%  
Dividend yield (eoy) %1.01.3 79.9%  
Book value per share (Unadj.) Rs188.7101.4 186.1%  
Shares outstanding (eoy) m2,399.341,023.74 234.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.92.0 145.5%   
Avg P/E ratio x22.924.3 94.1%  
P/CF ratio (eoy) x15.415.3 100.6%  
Price / Book Value ratio x2.12.8 76.8%  
Dividend payout %22.930.5 75.2%   
Avg Mkt Cap Rs m958,894286,034 335.2%   
No. of employees `000NANA-   
Total wages/salary Rs m63,62421,885 290.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m328,375142,531 230.4%  
Other income Rs m6,5161,171 556.4%   
Total revenues Rs m334,891143,702 233.0%   
Gross profit Rs m67,13524,166 277.8%  
Depreciation Rs m20,5286,965 294.7%   
Interest Rs m3,0273,418 88.6%   
Profit before tax Rs m50,09614,954 335.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,2283,198 257.3%   
Profit after tax Rs m41,86811,756 356.1%  
Gross profit margin %20.417.0 120.6%  
Effective tax rate %16.421.4 76.8%   
Net profit margin %12.88.2 154.6%  
BALANCE SHEET DATA
Current assets Rs m316,54287,154 363.2%   
Current liabilities Rs m157,06482,694 189.9%   
Net working cap to sales %48.63.1 1,552.0%  
Current ratio x2.01.1 191.2%  
Inventory Days Days15835 455.2%  
Debtors Days Days10594 111.6%  
Net fixed assets Rs m334,230141,183 236.7%   
Share capital Rs m2,3991,024 234.3%   
"Free" reserves Rs m450,245102,733 438.3%   
Net worth Rs m452,645103,757 436.3%   
Long term debt Rs m20,28932,146 63.1%   
Total assets Rs m650,772228,337 285.0%  
Interest coverage x17.55.4 326.5%   
Debt to equity ratio x00.3 14.5%  
Sales to assets ratio x0.50.6 80.8%   
Return on assets %6.96.6 103.8%  
Return on equity %9.211.3 81.6%  
Return on capital %11.213.5 83.1%  
Exports to sales %00-   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA14,504 0.0%   
Fx inflow Rs m74,21952,752 140.7%   
Fx outflow Rs m27,96414,504 192.8%   
Net fx Rs m46,25538,248 120.9%   
CASH FLOW
From Operations Rs m65,54825,054 261.6%  
From Investments Rs m-25,888-10,123 255.7%  
From Financial Activity Rs m-57,151-10,942 522.3%  
Net Cashflow Rs m-13,8573,989 -347.4%  

Share Holding

Indian Promoters % 54.5 74.9 72.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.3 16.5 201.4%  
FIIs % 11.7 5.2 223.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 25.1 181.2%  
Shareholders   709,045 223,384 317.4%  
Pledged promoter(s) holding % 8.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   MESCO PHARMA  KOPRAN.  HEMO ORGANIC  PARNAX LAB  KIMIA BIOSCIENCES  

Compare SUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Maruti Suzuki and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity today and ended on a flat note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Wednesday's Market Fall Explained(Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jun 22, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS